Third-line chemotherapy for resistant Hodgkin's disease with lomustine, etoposide, and methotrexate.

scientific article published in May 1987

Third-line chemotherapy for resistant Hodgkin's disease with lomustine, etoposide, and methotrexate. is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID3567972

P50authorSteven RosenbergQ2347448
P2093author name stringJacobs C
Coleman CN
Horning SJ
Lewis BJ
Tseng A Jr
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectetoposideQ418817
P304page(s)475-478
P577publication date1987-05-01
P1433published inCancer Treatment ReportsQ27710285
P1476titleThird-line chemotherapy for resistant Hodgkin's disease with lomustine, etoposide, and methotrexate
P478volume71

Reverse relations

cites work (P2860)
Q45289991An effective oral combination in advanced relapsed Hodgkin's disease prednisolone, etoposide, chlorambucil and CCNU.
Q33493801EPIC: an effective low toxicity regimen for relapsing lymphoma
Q40694333Etoposide: current status and future perspectives in the management of malignant neoplasms
Q54242190High-dose chemotherapy and hematopoietic stem cell rescue in patients with relapsed Hodgkin's disease.